Post
Early signals suggest oral SERD’s potential for more breast cancer patients
The Menarini Group today has announced exploratory results from its EMERALD clinical study that suggest its recently approved oral selective …
US companies drive 2023 drug launches positioned for blockbuster success by 2028
According to GlobalData's Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 …
AION Labs and BioMed X launch sixth challenge for AI-driven drug discovery
Last week, artificial intelligence (AI) innovator AION Labs called for applications for its latest AI-powered startup. In partnership with BioMed …
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter
Catalent’s (Somerset, NJ, US) CEO has admitted to the company’s “disappointing” and “poor performance” over the past quarter, and dropped …
Abiogen acquires EffRx to fortify bone disease portfolio
The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
AstriVax received €2.5 million government grant for thermostable vaccines
AstriVax has received a €2.5 million government grant from the Flanders Innovation & Entrepreneurship (VLAIO) agency that will be used …
SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine
SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine, …
Valneva seeks Health Canada approval for chikungunya vaccine
Valneva has submitted a regulatory application to Health Canada, seeking marketing approval for its chikungunya vaccine candidate, VLA1553. The vaccine is …
Roche Canada and pCPA conclude talks for Vabysmo eye therapy
Roche Canada has successfully concluded talks with the pan-Canadian Pharmaceutical Alliance (pCPA) for Vabysmo (faricimab injection). Vabysmo is administered into the …
Sun Pharma and Philogen sign licence agreement for anti-cancer therapy
Sun Pharmaceutical Industries has reached a licence agreement with Philogen for the commercialisation of Philogen's Nidlegy (Daromun) in Australia, New …
Amplo Biotechnology receives NIH-NIAMS grant for gene therapy AMP-201
Amplo Biotechnology has received a fast track phase I/II STTR grant from the NIH-NIAMS [National Institutes of Health's National Institute …
Medsenic amends licence agreement with Phebra for arsenic trioxide
Biotechnology company BioSenic’s affiliate Medsenic has amended its licence agreement with Australia-based pharmaceutical company Phebra for the oral formulation of …
Who’s saying what? Virtual Care mentions in company filings of pharmaceutical industry decreased by 38% in Q1 2023
The global pharmaceutical industry experienced a 38% drop in company filings mentions of virtual care in Q1 2023 compared with …
Who’s saying what? Regenerative Medicine mentions in company filings of pharmaceutical industry decreased by 24% in Q1 2023
The global pharmaceutical industry experienced a 24% drop in company filings mentions of regenerative medicine in Q1 2023 compared with …
Who’s saying what? Orphan Designated Drugs mentions in company filings of pharmaceutical industry decreased by 18% in Q1 2023
The global pharmaceutical industry experienced an 18% drop in company filings mentions of orphan designated drugs in Q1 2023 compared …